BREAKING: FDA Data Reanalysis Sent to Secretary Kennedy Finds Moderna’s mRNA Flu Shot Approval Should Be Immediately Withdrawn
We directly reanalyzed the FDA’s own data used to approve mFLUSIVA and found an extreme risk-benefit profile that is impossible to justify.